Magazine : 
U.S. Health Experts Express Concern Over Working Group On IP
WASHINGTON: The decision of India and the U.S. to establish a high-level working group on intellectual property will allow America to put "pressure" on India to expand liberal grants of drug patents in the country, independent American health care experts have warned.
"This working group will give the U.S. a dedicated forum to continue to pressure India to adopt TRIPS-plus IP measures, including repeal of section 3(d) of the India Patents Act, adoption of data exclusivity/monopolies, patent term extensions, and restrictions on the use of compulsory licenses," Professor Brook K Baker from the Northeastern University School of Law, said.
Agreeing on the need to foster innovation in a manner that promotes economic growth and job creation, President Barack Obama and Prime Minister Narendra Modi in a joint statement issued on Tuesday committed to establish an annual high-level Intellectual Property (IP) Working Group with appropriate decision-making and technical-level meetings as part of the Trade Policy Forum.
Baker argued that there will be efforts to strengthen enforcement measures and investor rights including investor/ state dispute resolution.
READ MORE: Entrepreneurs Should Learn From Gandhi
